Shares of Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY – Get Free Report) gapped down before the market opened on Tuesday . The stock had previously closed at $24.60, but opened at $23.20. Daiichi Sankyo shares last traded at $23.93, with a volume of 24,004 shares traded.
Wall Street Analysts Forecast Growth
Separately, Zacks Research downgraded shares of Daiichi Sankyo from a “hold” rating to a “strong sell” rating in a research note on Wednesday, November 19th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Daiichi Sankyo has an average rating of “Moderate Buy”.
Get Our Latest Stock Report on Daiichi Sankyo
Daiichi Sankyo Trading Down 2.7%
Daiichi Sankyo Company Profile
Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.
Recommended Stories
- Five stocks we like better than Daiichi Sankyo
- Large Cap Stock Definition and How to Invest
- NVIDIA’s $2B Power Play: Securing the Future of Chip Design
- How to buy stock: A step-by-step guide for beginners
- Insiders Swarm Vertical Aerospace Stock Ahead of Make-or-Break Reveal
- How to Profit From Growth Investing
- Symbotic Reanimates Market, Long-Term Targets Are Back In Focus
Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.
